Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.0750
0.00 (0.00%)
Sep 18, 2026, 9:22 AM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of CAD 4.69 million as of September 18, 2026. Its market cap has increased by 85.77% in one year.
Market Cap
4.69M
Enterprise Value
4.27M
Revenue
465.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 4.41M to 4.69M, an increase of 6.42%. That is a compound annual growth rate of 0.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 4.69M | -29.14% |
| Dec 31, 2025 | 6.62M | 512.13% |
| Dec 31, 2024 | 1.08M | -63.28% |
| Dec 29, 2023 | 2.94M | -79.49% |
| Dec 30, 2022 | 14.35M | 134.03% |
| Dec 31, 2021 | 6.13M | -74.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rakovina Therapeutics | 10.70M |
| Marvel Biosciences | 9.45M |
| Glow Lifetech | 7.70M |
| Kane Biotech | 6.15M |
| MYND Life Sciences | 5.22M |
| Grey Matters Health | 4.91M |
| PharmaTher Holdings | 4.55M |
| Innovotech | 4.36M |